Crossmark

Thrombotic microangiopathy associated with anticardiolipin antibody in a kidney transplant recipient with polycythemia

Crossref DOI link: https://doi.org/10.1007/s13730-018-0354-x

Published Online: 2018-08-02

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsuchimoto, Akihiro

Matsukuma, Yuta

Ueki, Kenji

Nishiki, Takehiro

Doi, Atsushi

Okabe, Yasuhiro

Nakamura, Masafumi

Tsuruya, Kazuhiko

Nakano, Toshiaki https://orcid.org/0000-0001-9235-5615
Kitazono, Takanari

Masutani, Kosuke
License Information

Text and Data Mining valid from 2018-08-02
More Information

Article History

Received: 25 January 2018

Accepted: 17 July 2018

First Online: 2 August 2018

Compliance with ethical standards

:

: The clinical and research activities of the study were consistent with the principles of the Declaration of Istanbul, as outlined in the Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Informed consent was acquired from the participant included in the study.

: The authors have no conflict of interest to declare.

: Ethical Approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number #24–54) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.